It has been reported that the prevalence of AS patients with bone loss is about 25% and low vertebral bone mineral density in AS is closely associated with high modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) and C-reactive protein (CRP) [17, 18]. The gene discussed is CRP; the disease is spondylitis.